User Fee programs help the Food and Drug Administration (FDA) to ensure timely review and support the development of innovative therapeutics.
OTC Monograph User Fee Public Meeting Remarks
Published June 10, 2016
These are remarks made by Alliance Vice President of Public Policy Cynthia Bens at the U.S. Food and Drug Administration’s public meeting on OTC Monograph User Fees on June 10, 2016.